Trials / Recruiting
RecruitingNCT05810571
Comparison of Postoperative Analgesic Efficacy of the Erector Spina Plane Block and Quadratus Lumborum Block in Open Nephrectomy: a Prospective Randomized Clinical Study
Comparison of Erector Spina and Quadratus Lumborum in Open Nephrectomy
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Kocaeli University · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
patients who will undergo elective open nephrectomy will be divided into three groups; the control (PCA), the erector spina plane block, and the quadratus lumborum block. After standard anesthesia induction and monitorization then Bispectral index monitoring will be applied to all patients. Anesthesia will be maintained using sevoflurane in a mixture of oxygen and air. Continuous remifentanil infusion will be used for analgesia. Then patient's numeric rating scales and morphine pca consumptions will be recorded for one day.
Detailed description
patients who will undergo elective open nephrectomy will be divided into three groups; the control (PCA), the erector spina plane block and the quadratus lumborum block. After standard anesthesia induction and monitorization then Bispectral index monitoring will be applied to all patients. Anesthesia will be maintained using sevoflurane in a mixture of oxygen and air. Continious remifentanil infusion will be used for analgesia. Then patient's numeric rating scales and morphine pca consumptions will be recorded for one day.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | preoperative remifentanil consumption | continuous remifentanil infusion will applied for peroperative analgesia |
| PROCEDURE | postopeartive controlled anlagesia with morphine | postoperative morphine patient controlled analgesia will be applied for postoperative analgesia |
Timeline
- Start date
- 2024-10-24
- Primary completion
- 2027-01-03
- Completion
- 2027-01-03
- First posted
- 2023-04-12
- Last updated
- 2024-10-26
Locations
2 sites across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT05810571. Inclusion in this directory is not an endorsement.